Related Experiment Video
Updated: Sep 18, 2025

11:07
Focal Laser Ablation of Prostate Cancer: An Office Procedure
Published on: March 30, 2021
8.0K
Evolution of Image Guidance and Adaptive Radiation Therapy for Localized Prostate Cancer.
Rohan K Patel1, Joan Lee1, Maitry Patel1
1Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, Ohio.
Summary
Radiation therapy (RT) has evolved significantly for prostate cancer management. Modern techniques like adaptive RT improve treatment precision, reduce side effects, and enhance patient outcomes.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Physics
Background:
- Radiation therapy (RT) has been a cornerstone in prostate cancer treatment for over 50 years.
- Significant advancements in radiobiology and technology have refined RT practices.
- The primary goal is to optimize therapeutic efficacy while minimizing toxicity to surrounding tissues.
Purpose of the Study:
- To review the historical evolution of radiation therapy techniques for prostate cancer.
- To highlight the impact of technological innovations on RT safety and efficacy.
- To discuss the current state and future implications of adaptive RT in prostate cancer care.
Main Methods:
- Review of radiation therapy techniques from 2D planning to advanced image-guided methods.
- Examination of 3D conformal RT, IMRT, VMAT, and adaptive RT approaches.
- Analysis of the role of CT and MRI in online adaptive RT.
Main Results:
- RT techniques have progressed from 2D to sophisticated methods like online adaptive RT.
- Modern RT approaches have dramatically improved safety and efficacy, reducing toxicities.
- Indications for RT have expanded to localized, recurrent, and metastatic prostate cancer.
Conclusions:
- Technological advancements have significantly enhanced the therapeutic ratio in prostate cancer RT.
- Online adaptive RT allows for real-time dose adjustments, improving treatment precision.
- Continued innovation in RT promises further improvements in local control and patient outcomes for prostate cancer.

